NRIX
Nurix Therapeutics Inc
22.70$
+0.6%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +2.2% | +12.1% | -82.4% | +53.8% | +46.0% | -2.3% | +63.7% | -25.1% | +41.5% | +44.6% | -27.9% | +30.1% | +18.8% | -5.6% | -37.1% | +87.0% | +141.8% | -39.8% | -17.9% | +9.4% | -27.1% | +4.1% | +5.5% | +38.9% | +138.7% | -82.1% | +72.0% | -54.0% | +44.6% | – | |
| – | +3.1% | +2.3% | +16.5% | +1.1% | +9.1% | +33.9% | +8.0% | +12.5% | +13.0% | +18.9% | +18.2% | +18.1% | +10.1% | +0.6% | -3.5% | -0.6% | -0.1% | +4.6% | +3.9% | +0.6% | -2.2% | +13.4% | +21.2% | +3.6% | +12.1% | -93.6% | -7.4% | +1,716.8% | -95.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +209.1% | -970.6% | – | – | |
| – | +3.1% | +2.3% | +16.5% | +1.1% | +9.1% | +33.9% | +8.0% | +12.5% | +13.0% | +18.9% | +18.2% | +18.1% | +10.1% | +0.6% | -3.5% | -0.6% | -0.1% | +4.6% | +3.9% | +0.6% | -2.2% | +13.4% | +21.2% | +3.6% | +12.1% | +10.3% | -6.1% | +4.0% | +4.2% | – | |
| – | +12.0% | +16.8% | +19.1% | -5.8% | +33.5% | +32.7% | +44.1% | +4.4% | +15.0% | +11.1% | +5.7% | +4.6% | +4.6% | +1.0% | -3.9% | +4.8% | +18.9% | -9.0% | +1.5% | +9.5% | -0.8% | +0.1% | -8.5% | +8.7% | +22.6% | -7.9% | +3.7% | +7.0% | +6.7% | – | |
| – | +12.0% | +16.8% | +19.1% | -5.8% | +33.5% | +32.7% | +44.1% | +4.4% | +15.0% | +11.1% | +5.7% | +4.6% | +4.6% | +1.0% | -3.9% | +4.8% | +18.9% | -9.0% | +1.5% | +9.5% | -0.8% | +0.1% | -8.5% | +8.7% | +22.6% | +560.1% | -2.4% | -84.1% | +580.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +30.8% | -32.2% | +28.9% | +202.7% | -80.0% | +135.6% | -46.2% | -77.2% | +656.4% | -28.5% | +48.8% | +221.3% | +396.5% | +7.8% | -53.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +11.1% | +0.0% | +2,000.0% | -94.8% | -187,254.5% | – | – | +73.2% | +95.8% | -188.5% | – | -579.5% | – | – | – | – | – | – | +130.4% | -98.9% | +0.0% | -8.9% | -90.2% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -344.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.